SARS-CoV-2 Nucleocapsid Protéines
(SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N))
Filtrer les résultats:
52 Résultats
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
5 références
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
> 95 % as determined by Bis-Tris PAGE
Active
1 image
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
> 95 % as determined by Bis-Tris PAGE
Active
1 image
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
> 95 % as determined by Bis-Tris PAGE
Active
1 image
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: CHO Cells
Recombinant
>95 % as determined by SDS-PAGE and HPLC
1 image
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
The purity of the protein is greater than 85 % as determined by SDS-PAGE and Coomassie blue staining.
IA, AM, ADA, ScA
1 image
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
The purity of the protein is greater than 85 % as determined by SDS-PAGE and Coomassie blue staining.
IA, AM, ADA, ScA
1 image
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
>90 % as determined by SDS-PAGE.
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Omicron
Hôte: HEK-293 Cells
Recombinant
> 95% as determined by SDS-PAGE.
ELISA, SDS
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
>90 % as determined by SDS-PAGE.
Active
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Active
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Active
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
> 95 % by SDS-PAGE.> 95 % by HPLC.
Active
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Human Cells
Recombinant
Greater than 95 % as determined by reducing SDS-PAGE.
Active
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Baculovirus infected Insect Cells
Recombinant
> 90 % by SDS-PAGE.
Active
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
>95 % (SDS-PAGE)
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
Greater than 95 % as determined by reducing SDS-PAGE.
Active
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
>90 % as determined by SDS-PAGE.
SARS-CoV-2 N
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
>90 % as determined by SDS-PAGE.
Dernières publications pour nos SARS-CoV-2 Nucleocapsid Protéines
: "Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Issue 5, (2021) (PubMed).: "SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus." dans: Communications biology, Vol. 4, Issue 1, pp. 129, (2021) (PubMed).
: "Variable post-translational modifications of SARS-CoV-2 nucleocapsid protein." dans: Glycobiology, (2021) (PubMed).
: "Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin." dans: bioRxiv : the preprint server for biology, (2021) (PubMed).
: "An antigen microarray protocol for COVID-19 serological analysis." dans: STAR protocols, Vol. 2, Issue 3, pp. 100815, (2021) (PubMed).
: "38" dans: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)
: "SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. ..." dans: Nature communications, Vol. 11, Issue 1, pp. 5064, (2020) (PubMed).
Pseudonymes pour SARS-CoV-2 Nucleocapsid Protéines
nucleocapsid phosphoprotein (N) ProtéinesAvez-vous cherché autre chose?
- SARS-CoV-2 NSP5 (3CL-Pro) Protéines
- SARS-CoV-2 Non-Structural Protein 7 Protéines
- SARS-CoV Spike Protéines
- SARS-Coronavirus Nucleocapsid Protein Protéines
- SARS-Coronavirus Membrane Protein Protéines
- SARNP Protéines
- SARM1 Protéines
- SARDH Protéines
- Sarcolemma Associated Protein Protéines
- Sarcalumenin Protéines
- SAR1B Protéines
- SAR1A Protéines
- SAPS2 Protéines
- SAPS1 Protéines
- SAP30BP Protéines
- SAP30-Like Protéines
- SAP30 Protéines
- SAP18 Protéines
- SAP1 Protéines
- SAMM50 Protéines
- SARS-CoV-2 Papain-Like Protease Protéines
- SARS-CoV-2 Spike Protéines
- SARS-CoV-2 Spike S1 Protéines
- SARS-CoV-2 Spike S2 Protéines
- SARS2 Protéines
- SART1 Protéines
- SART3 Protéines
- SASH1 Protéines
- SASH3 Protéines
- SAT1 Protéines
- SAT2 Protéines
- SATB1 Protéines
- SATB2 Protéines
- SAV1 Protéines
- SBDS Protéines
- SBEM Protéines
- SBK1 Protéines
- SBNO1 Protéines
- SC4MOL Protéines
- SC5DL Protéines
Vous êtes ici:
